Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with Lu-177-DOTATATE
Year: 2025
Type: conference-abstract
Source: Endocrine Abstracts
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408303340
